サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1356792

排卵障害診断市場レポート：2030年までの動向、予測、競合分析

Ovulation Disorder Diagnosis Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

排卵障害診断市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年09月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

排卵障害診断の動向と予測

世界の排卵障害診断市場は、2024年から2030年までのCAGRが6.1％で、2030年までに推定8億米ドルに達すると予想されます。この市場の主な促進要因は、計画妊娠の採用の増加、さまざまな排卵障害に対する意識の高まり、出生率の低下です。世界の排卵障害診断市場の将来は、病院、婦人科クリニック、診断センター市場における機会によって有望視されています。

排卵障害診断市場の洞察

Lucintelの予測では、多嚢胞性卵巣症候群は、2型糖尿病患者におけるPCOD発症率の増加により、予測期間中に最も高い成長が見込まれます。

この市場において、病院は引き続き最大のセグメントです。

北米は、高度なヘルスケアインフラの存在と排卵障害診断に対する一般市民の意識の高まりにより、予測期間中に最も高い成長が見込まれます。

本レポートでは、以下の11の主要な質問に回答しています：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.今後成長が加速するセグメントとその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の排卵障害診断市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の排卵障害診断市場動向（2018～2023年）と予測（2024～2030年）
  • 排卵障害別の世界の排卵障害診断市場
    • 多嚢胞性卵巣症候群
    • 高プロラクチン血症
    • 黄体期欠損
    • 視床下部機能不全
    • 腫瘍
    • 自己免疫性卵巣炎
    • 原発性卵巣不全
    • 抵抗性卵巣症候群
    • その他
  • 診断別の世界の排卵障害診断市場
    • ホルモンの臨床検査
    • 下垂体と視床下部のCTスキャンとMRIスキャン
    • 卵巣生検
    • その他
  • 最終用途別の世界の排卵障害診断市場
    • 病院
    • 婦人科クリニック
    • 診断センター
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の排卵障害診断市場
  • 北米の排卵障害診断市場
  • 欧州の排卵障害診断市場
  • アジア太平洋の排卵障害診断市場
  • その他地域排卵障害診断市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 排卵障害別の世界の排卵障害診断市場の成長機会
    • 診断別の世界の排卵障害診断市場の成長機会
    • 最終用途別の世界の排卵障害診断市場の成長機会
    • 地域別の世界の排卵障害診断市場の成長機会
  • 世界の排卵障害診断市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の排卵障害診断市場の能力拡大
    • 世界の排卵障害診断市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Siemens Healthcare
  • GE Healthcare
  • Fujifilm Holdings
  • Swiss Precision Diagnostics
  • Toshiba Medical Systems
  • Carestream Health
  • Genova Diagnostics
  • Quest Diagnostics
  • LabCorp
  • Esaote
目次

Ovulation Disorder Diagnosis Trends and Forecast

The future of the global ovulation disorder diagnosis market looks promising with opportunities in the hospital, gynecological clinic, and diagnostic center markets. The global ovulation disorder diagnosis market is expected to reach an estimated $0.8 billion by 2030 with a CAGR of 6.1% from 2024 to 2030. The major drivers for this market are increasing adoption of planned pregnancies, growing awareness towards different ovulation disorders, and decrease in fertility rate.

A more than 150-page report is developed to help in your business decisions.

Ovulation Disorder Diagnosis by Segment

The study includes a forecast for the global ovulation disorder diagnosis by ovulation disorders, diagnosis, end use, and region.

Ovulation Disorder Diagnosis Market by Ovulation Disorders [Shipment Analysis by Value from 2018 to 2030]:

  • Polycystic Ovarian Syndrome
  • Hyperprolactinemia
  • Luteal Phase Defect
  • Hypothalamus Dysfunction
  • Tumors
  • Autoimmune Oophoritis
  • Primary Ovarian Failure
  • Resistant Ovary Syndrome
  • Others

Ovulation Disorder Diagnosis Market by Diagnosis [Shipment Analysis by Value from 2018 to 2030]:

  • Laboratory Testing of Hormones
  • CT Scan and MRI Scan of The Pituitary Gland and Hypothalamus
  • Ovarian Biopsy
  • Others

Ovulation Disorder Diagnosis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Gynecological Clinics
  • Diagnostic Centers
  • Others

Ovulation Disorder Diagnosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Ovulation Disorder Diagnosis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies ovulation disorder diagnosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ovulation disorder diagnosis companies profiled in this report include-

  • Siemens Healthcare
  • GE Healthcare
  • Fujifilm Holdings
  • Swiss Precision Diagnostics
  • Toshiba Medical Systems
  • Carestream Health
  • Genova Diagnostics
  • Quest Diagnostics
  • Labcorp
  • Esaote

Ovulation Disorder Diagnosis Market Insights

Lucintel forecasts that polycystic ovarian syndrome is expected to witness highest growth over the forecast period due to increasing incidence of PCOD in patients with type 2 diabetes.

Within this market, hospitals will remain the largest segment .

North America is expected to witness highest growth over the forecast period due to presence of advanced healthcare infrastructure and growing awareness in public towards ovulation disorder diagnosis.

Features of the Global Ovulation Disorder Diagnosis Market

Market Size Estimates: Ovulation disorder diagnosis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Ovulation disorder diagnosis market size by ovulation disorders, diagnosis, end use, and region. in terms of value ($B).

Regional Analysis: Ovulation disorder diagnosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different ovulation disorders, diagnosis, end uses, and region.s for the ovulation disorder diagnosis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the ovulation disorder diagnosis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the ovulation disorder diagnosis market size?

Answer: The global ovulation disorder diagnosis market is expected to reach an estimated $0.8 billion by 2030.

Q.2. What is the growth forecast for ovulation disorder diagnosis market?

Answer: The global ovulation disorder diagnosis market is expected to grow with a CAGR of 6.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the ovulation disorder diagnosis market?

Answer: The major drivers for this market are increasing adoption of planned pregnancies, growing awareness towards different ovulation disorders, and decrease in fertility rate.

Q.4. What are the major segments for ovulation disorder diagnosis market?

Answer: The future of the global ovulation disorder diagnosis market looks promising with opportunities in the hospital, gynecological clinic, and diagnostic center markets.

Q.5. Who are the key ovulation disorder diagnosis market companies?

Answer: Some of the key ovulation disorder diagnosis companies are as follows:

  • Siemens Healthcare
  • GE Healthcare
  • Fujifilm Holdings
  • Swiss Precision Diagnostics
  • Toshiba Medical Systems
  • Carestream Health
  • Genova Diagnostics
  • Quest Diagnostics
  • LabCorp
  • Esaote

Q.6. Which ovulation disorder diagnosis market segment will be the largest in future?

Answer: Lucintel forecasts that polycystic ovarian syndrome is expected to witness highest growth over the forecast period due to increasing incidence of PCOD in patients with type 2 diabetes.

Q.7. In ovulation disorder diagnosis market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to presence of advanced healthcare infrastructure and growing awareness in public towards ovulation disorder diagnosis.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the ovulation disorder diagnosis market by ovulation disorders (polycystic ovarian syndrome, hyperprolactinemia, luteal phase defect, hypothalamus dysfunction, tumors, autoimmune oophoritis, primary ovarian failure, resistant ovary syndrome, and others), diagnosis (laboratory testing of hormones, CT scan & MRI scan of the pituitary gland & hypothalamus, ovarian biopsy, and others), end use (hospitals, gynecological clinics, diagnostic centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Ovulation Disorder Diagnosis Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Ovulation Disorder Diagnosis Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Ovulation Disorder Diagnosis Market by Ovulation Disorders
    • 3.3.1: Polycystic Ovarian Syndrome
    • 3.3.2: Hyperprolactinemia
    • 3.3.3: Luteal Phase Defect
    • 3.3.4: Hypothalamus Dysfunction
    • 3.3.5: Tumors
    • 3.3.6: Autoimmune Oophoritis
    • 3.3.7: Primary Ovarian Failure
    • 3.3.8: Resistant Ovary Syndrome
    • 3.3.9: Others
  • 3.4: Global Ovulation Disorder Diagnosis Market by Diagnosis
    • 3.4.1: Laboratory Testing of Hormones
    • 3.4.2: CT Scan and MRI Scan of The Pituitary Gland and Hypothalamus
    • 3.4.3: Ovarian Biopsy
    • 3.4.4: Others
  • 3.5: Global Ovulation Disorder Diagnosis Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Gynecological Clinics
    • 3.5.3: Diagnostic Centers
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Ovulation Disorder Diagnosis Market by Region
  • 4.2: North American Ovulation Disorder Diagnosis Market
    • 4.2.2: North American Ovulation Disorder Diagnosis Market by End Use: Hospitals, Gynecological Clinics, Diagnostic Centers, and Others
  • 4.3: European Ovulation Disorder Diagnosis Market
    • 4.3.1: European Ovulation Disorder Diagnosis Market by Ovulation Disorders: Polycystic Ovarian Syndrome, Hyperprolactinemia, Luteal Phase Defect, Hypothalamus Dysfunction, Tumors, Autoimmune Oophoritis, Primary Ovarian Failure, Resistant Ovary Syndrome, and Others
    • 4.3.2: European Ovulation Disorder Diagnosis Market by End Use: Hospitals, Gynecological Clinics, Diagnostic Centers, and Others
  • 4.4: APAC Ovulation Disorder Diagnosis Market
    • 4.4.1: APAC Ovulation Disorder Diagnosis Market by Ovulation Disorders: Polycystic Ovarian Syndrome, Hyperprolactinemia, Luteal Phase Defect, Hypothalamus Dysfunction, Tumors, Autoimmune Oophoritis, Primary Ovarian Failure, Resistant Ovary Syndrome, and Others
    • 4.4.2: APAC Ovulation Disorder Diagnosis Market by End Use: Hospitals, Gynecological Clinics, Diagnostic Centers, and Others
  • 4.5: ROW Ovulation Disorder Diagnosis Market
    • 4.5.1: ROW Ovulation Disorder Diagnosis Market by Ovulation Disorders: Polycystic Ovarian Syndrome, Hyperprolactinemia, Luteal Phase Defect, Hypothalamus Dysfunction, Tumors, Autoimmune Oophoritis, Primary Ovarian Failure, Resistant Ovary Syndrome, and Others
    • 4.5.2: ROW Ovulation Disorder Diagnosis Market by End Use: Hospitals, Gynecological Clinics, Diagnostic Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Ovulation Disorder Diagnosis Market by Ovulation Disorders
    • 6.1.2: Growth Opportunities for the Global Ovulation Disorder Diagnosis Market by Diagnosis
    • 6.1.3: Growth Opportunities for the Global Ovulation Disorder Diagnosis Market by End Use
    • 6.1.4: Growth Opportunities for the Global Ovulation Disorder Diagnosis Market by Region
  • 6.2: Emerging Trends in the Global Ovulation Disorder Diagnosis Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Ovulation Disorder Diagnosis Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Ovulation Disorder Diagnosis Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Siemens Healthcare
  • 7.2: GE Healthcare
  • 7.3: Fujifilm Holdings
  • 7.4: Swiss Precision Diagnostics
  • 7.5: Toshiba Medical Systems
  • 7.6: Carestream Health
  • 7.7: Genova Diagnostics
  • 7.8: Quest Diagnostics
  • 7.9: LabCorp
  • 7.10: Esaote